Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
573.8 INR | +0.38% | -1.03% | +32.72% |
Feb. 14 | Balaxi Pharmaceuticals Limited Incorporates New Wholly Owned Subsidiary in Chile | CI |
Feb. 09 | Balaxi Pharmaceuticals Limited Announces Update on Company's Pharmaceutical Formulation Plant | CI |
Sales 2021 | 2.31B 27.75M | Sales 2022 | 2.79B 33.51M | Capitalization | 3.52B 42.17M |
---|---|---|---|---|---|
Net income 2021 | 381M 4.57M | Net income 2022 | 477M 5.72M | EV / Sales 2021 | 2.28 x |
Net Debt 2021 | 19.9M 239K | Net cash position 2022 | 37.39M 448K | EV / Sales 2022 | 1.25 x |
P/E ratio 2021 |
13.8
x | P/E ratio 2022 |
7.38
x | Employees | 400 |
Yield 2021 * |
-
| Yield 2022 |
0.14% | Free-Float | 89.66% |
1 day | +0.38% | ||
1 week | -1.03% | ||
Current month | +15.70% | ||
1 month | +16.14% | ||
3 months | +32.20% | ||
6 months | +35.62% | ||
Current year | +32.72% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 42-09-27 | |
Director of Finance/CFO | - | 11-12-31 | |
Udayan Shukla
CMP | Compliance Officer | - | 22-10-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 42-09-27 | |
Founder | 51 | - | |
Director/Board Member | 42 | 17-05-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 573.8 | +0.38% | 515 |
24-04-24 | 571.6 | -0.28% | 3,629 |
24-04-23 | 573.2 | +0.17% | 3,717 |
24-04-22 | 572.2 | -0.44% | 7,649 |
24-04-19 | 574.8 | -0.87% | 4,082 |
Delayed Quote NSE India S.E., April 25, 2024 at 12:16 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+32.72% | 69.68M | |
+15.65% | 70.36B | |
+2.72% | 25.18B | |
+5.13% | 8.61B | |
+6.10% | 8.14B | |
-21.85% | 7.83B | |
+0.73% | 4.56B | |
+17.40% | 4.32B | |
-0.14% | 4.06B | |
-2.34% | 3.87B |
- Stock Market
- Equities
- BALAXI Stock